Gland Pharma Fundamentals
P/E Ratio
34.05
P/B Ratio
2.94
Div. Yield
1.03
Sector P/E
65.48
Sector P/B
3.51
Sec. Div. Yield
0.57
Gland Pharma Fundamentals is currently trading with a P/E Ratio of 34.05, compared to the sector average of 65.48. Its P/B Ratio stands at 2.94, while the sector’s is 3.51. In terms of returns, the stock offers a Dividend Yield of 1.03%, which is than the sector’s 0.57%.
Gland Pharma Score Card
Price
Attractive
Growth
Moderate
Quality
Good
Management
Good
On its scorecard, Gland Pharma reflects: Price – Attractive, Growth – Moderate, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
